🇺🇸 FDA
Pipeline program

CG0070

BOND 2 version 3.8

Phase 2 mab completed

Quick answer

CG0070 for Bladder Cancer is a Phase 2 program (mab) at CG Oncology with 1 ClinicalTrials.gov record(s).

Program details

Company
CG Oncology
Indication
Bladder Cancer
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials